Articles related to CONTRACEPTION/PREGNANCY

New research identifies the placenta as a significant factor in schizophrenia risk, revealing more than 100 genes that impact the disorder and suggesting new avenues for prevention and treatment.

This landmark study provides crucial insights into the safety of anti-seizure medications during pregnancy, offering both reassurance to prospective mothers and important guidelines for healthcare providers.

This case study reveals the ethical and medical dilemmas that can arise from non-disclosure of mental health conditions in postpartum care. Learn how this lack of transparency impacted both the patient and her newborn, and what it means for medical ethics and patient safety.

New research indicates that maternal hemoglobin levels can significantly impact both maternal and neonatal health outcomes, suggesting a need for revised antenatal care guidelines.

Melasma is a complex condition with dermatological and psychological implications; early recognition and preventive measures can significantly impact patient outcomes. Learn more about the role primary care physicians can play in managing this challenging condition.

The FDA’s approval of Zurzuvae (zuranolone) as the first oral treatment for postpartum depression represents a significant advancement in patient care. Physicians are encouraged to explore this new option, considering both its proven efficacy and accompanying warnings, to provide more accessible care for those struggling with this serious condition.